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INTRODUCTION 
 
Vesico ureteral reflux is a dynamic event – the retrograde flow of 
bladder urine into the upper urinary tracts. It’s a feature of disordered 
anatomy and function at the uretero vesical junction. 
Although this reflux nephropathy may disappear during growth, it is 
of clinical concern because of the morbidity from ascending urinary 
infection and associated nephropathy that can lead to hypertension and 
renal function insufficiency. 
To reduce the morbidity and mortality associated with vesico 
ureteric reflux, there are many studies available all over the world with 
relation to the pre-op work up, medical and surgical management, post 
operative follow up and outcome. 
So, we have undertaken this study on “An analysis of post surgical 
outcome in primary vesico ureteric reflux (VUR) patients” at Institute of 
Child Health, Madras Medical College, Chennai-8. 
 
8 
AIMS AND OBJECTIVES OF THE STUDY 
 
The aim of the study is  
 To analyse the post surgical outcome in primary vesico-
ureteral reflux patients with the clinical and imaging 
parameters in the follow up. 
 To analyse the primary vesico ureteral reflux treated 
surgically with those treated by chemoprophylaxis alone. 
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REVIEW OF LITERATURE 
The ureters are bilateral tubular structures responsible for 
transporting urine from the renal pelvis to the bladder. They are generally 
22 to 30 cm in length. 
During the 4th week of gestation, the development of the ureter 
begins as an outpouching of the mesonephric duct, termed the ureteric 
bud. The development of this structure is heavily influenced by molecular 
factors released from the mesodermal tissue mass, which is destined  
to become the renal parenchyma (i.e. the metanephric blastema)1.  
At 28 days, the ureter consists of an epithelial tube surrounded by loose 
mesenchymal cells. Transient luminal obstruction ensues, with subsequent 
recanalization during the 7th week of gestation. It appears that this 
recanalization process begins in the midureter and extends in a 
bidirectional manner both cranially and caudally. It has been suggested 
that angiotensin exerts its effect through angiotensin 2 receptor (AT2) and 
may play a role in this recanalization process. Chwalle's membrane, a two-
layered cell structure, transiently divides the early ureteric bud from the 
urogenital sinus. Subsequent dissolution of this membrane results in 
unimpeded flow of urine from the kidney into the bladder. 
The first signs of ureteral muscularization2 are seen at 12 weeks of 
gestation. Smooth muscle differentiation is first noted at the ureterovesical 
junction (UVJ) and then ascends cranially towards the upper collecting 
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system. With time, these fibers, which are initially randomly arranged in 
the wall of the ureter, become more numerous and assume a more specific 
orientation. The epithelium attains a transitional configuration by 14 
weeks. Once fully developed, the muscular wall of the ureter is 
characterized as having an inner longitudinal, middle circular, and outer 
longitudinal layer. As the ureter penetrates the bladder, its muscular layers 
disperse. The outer layer melts into the detrusor in the upper part of the 
hiatus to form Waldeyer's sheath, which attaches the ureter to the bladder 
and is in continuity with the deep trigone. As the ureter makes its 
transition to an intramural location, the muscle fibres take on a primarily 
longitudinal orientation. The longitudinal muscle fibers spread out to form 
the borders of the superficial trigone. 
Proper development and spatial orientation of the ureter as it 
combines with the bladder are dependent on a number of molecular 
factors. The renin-angiotensin system3 appears to play a major role in 
ureteral development. Angiotensin 2 is expressed in high concentration by 
the mesenchymal cells that are positioned adjacent to the ureteric bud at 
an early developmental stage. The fact that expression of this receptor 
markedly decreases after birth supports the contention that angiotensin 2 
might play an important role in ureteral development. Mice in whom the 
angiotensin 2 gene has been knocked-out demonstrate a high incidence of 
congenital anomalies of the urinary tract, including VUR, UVJ obstruction, 
and megaureter. These structural anomalies may result from delayed 
apoptosis of the mesenchymal cells surrounding the ureteric bud.  
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The clinical relevance of these experimental findings has been 
underscored by the identification of a select group of patients with 
mutations at this locus who possess a syndrome that includes 
ureteropelvic junction (UPJ) obstruction and megaureter. Proper spatial 
orientation of the ureter is probably dependent on genes responsible for 
cell specification and body segmentation. The PAX family of genes has 
been extensively studied in this regard. These genes appear to play a role 
in the interplay between the ureter and the developing kidney. PAX 
mutations have been implicated in syndromes with VUR and renal 
anomalies and are inherited in an autosomal dominant manner. However, 
to date, neither mutations in the PAX genes nor in other genes involving 
body segmentation have been demonstrated to any significant degree in 
patients with familial VUR. 
 
Embryology of ureter and trigone. The ureteral bud develops into the  
ureter and induces the metanephric blastema to differentiate and become the 
kidney. The common excretory duct (segment of mesonephric duct caudal to 
the ureteric bud) is absorbed into the bladder and becomes the deep trigone. 
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Vesico Ureteral Reflux (VUR) is a dynamic event – the retrograde 
flow of bladder urine into the upper urinary tracts. Though it occurs 
normally in the young of many animal species, it is considered abnormal 
in humans. It is a feature of disordered anatomy and function at the 
ureterovesical junction (UVJ). In practice, VUR describes a common 
primary disorder of childhood associated with urinary infection and renal 
scarring, or reflux nephropathy. Although the reflux event usually 
disappears during growth, the disorder is of clinical concern because of 
the morbidity from ascending urinary infection and the associated 
nephropathy that can lead to hypertension and renal function insufficiency. 
Many studies have been directed at isolating the causal 
relationships between the pathophysiologic components of the VUR 
disorder, the reflux event, the urinary infection and the associated 
nephropathy. The VUR disorder in overall is a heterogenous condition 
with diverse features, suggesting that compound factors may operate in 
the genesis of the reflux and its relationships with urinary infection and 
nephropathy. 
Most studies are concerned with older children with acquired renal 
scarring. Most children presenting in clinical practice do so after urinary 
infection and already have renal scarring. 
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VUR – the Anomaly: 
VUR was first documented in 1893, when Pozzi noted the reflux of 
urine from the distal segment of a ureter accidentally severed during pelvic 
surgery.Prevalance is 1-2%. 
When prenatal USG is used for screening, foctus with a prenatal 
renal pelvis dilatation is greater than or equal to 4mm, identified VUR is 
6.9%, with an incidence of 0.44% of the population screened by prenatal 
USG. In infants investigated after an established and specific diagnosis of 
prenatal hydronephrosis, the incidence increases to 15% to 25%, i.e. a 
prevalence rate of 0.02% to 0.2%. Prenatal screening identifies only a few 
of all children who present with VUR at some stage. 
Investigations after clinical presentation with urinary infection show 
reflux present in 30%-50%. Boys present predominantly in the first year of 
life often with severely dilated upper urinary tracts and often congenital 
nephropathy. Girls present cumulatively throughout childhood and have 
less upper tract dilatation. By the age of 2 years, girls presenting with VUR 
slightly exceeds boys and thereafter girls predominate. 
VUR may have a genetic basis, as there is an incidence of 32% 
among siblings (100% for identitical twins and if a parent is affected, the 
risk increases to 69%). No specific gene has been identified yet. 
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Ureterovesical Junction: 
The UVJ is structurally and functionally adapted to allow the 
intermittent passage of ureteral urine and to prevent the reflux of bladder 
urine. For this the ureter enters the bladder with an oblique intramural 
passage which extends submucosally to open onto the trigone. 
Reflux is prevented by active and passive components, the natural 
tonus of the ureteral muscles maintains an active closure of the 
intravesical ureter except during the efflux of urine. The longitudinal 
urethral muscles intermingle with those of the (superficial) trigone and the 
contralateral ureter so that contraction elongates the submucosal tunnel. 
The adventitia fuses with a fibrous sheath (Waldeyer)4. Circumferentially 
allowing the intramural ureter to move within the hiatus during bladder 
filling. As the bladder fills and becomes distended, there is progressive 
obliquity of the intravesical ureter, the trigone is progressively stretched, 
increasing resistance in the intravesical ureter and causing increased 
pressure within the distal end of the ureter.  
During micturition, when the trigone is stimulated, the intravesical 
ureter is pulled downward and the ureteral walls are compressed against 
the supporting vesical wall as a passive reinforcement of the valvular 
mechanism. These actions anchor the ureter, retaining its correct 
configuration and preventing lateral displacement of the ureteral orifice. 
The mechanism requires a complex of muscular components that includes 
ureteral and vesical muscle bundles and an elaborate neural influence. 
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Neurohistochemistry has defined a dual autonomic innervation by 
cholinergic and nor adrenergic nerves, and these is evidence for 
neuropeptides that may act as neuromodulators. 
 
The classical view of the ureterovesical junction. The ureter enters the bladder with  
an oblique passage to open onto the trigone. There is a seamless continuity between the 
ureter and the trigone, which extends in males to the verumontanum. The adventitia fuses 
with Waldeyer sheath. The longitudinal ureteral muscles extend and fuse with the  
uscles of the opposite ureter to form the superficial trigone. 
Immunohistochemistry has revealed further abundant innervation at 
the UVJ and numerous nitric oxide synthase immuno reactive nerves that 
may have a regulatory role, as evidenced from separate  biochemical and 
functional studies. 
Genesis of VUR: 
The well accepted explanation is immaturity affecting the length of 
the submucosal tunnel5 in younger children and its spontaneous resolution 
during growth. The intravesical ureter (the intramural segment and the 
submucosal tunnel) lengthen from 0.5cm in neonates to 1.3 cm in adults, 
the mature length is achieved by 10-12 years of age. 
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Factors: 
 Short intravesical ureter 
 Trigonal and distal ureteral muscle deficiency. 
 Reduced nerve supply 
 Disordered extracellular matrix. 
 Ureteral muscle atrophy and dysplasia at VUJ. 
 
The position of the ureteral bud on the wolffian (mesonephric) duct  corresponds to the final 
position of the ureteral orifice and differentiation of the metanephric blastema. Lateral  
and caudal ectopia can both result in renal dysplasia (Meckie and Stephans). 
Induction and Orientation of the ureteral bud & renal development: 
Primary VUR is an abnormal UVJ with maldevelopment, 
malfunction or delayed maturity. Secondary VUR is associated with 
outflow obstruction. 
In terms of the low pressure / high pressure reflux – the worse renal 
prognosis is often seen in the low pressure group in which reflux occurs 
freely from early in the filling phase through golf hole orifices into highly 
abnormal kidneys. 
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Whereas high pressure reflux was a secondary effect occurring at 
high pressures either late in filling or in voiding when bladder function was 
abnormal and finally overcome the resistance at the VUJ.  
Spontaneous resolution documented by contrast study by the 
international Reflux study reported a 28% resolution rate after 5 years and 
47% after 10 years. For older population with grades III & IV reflux-in 
boys faster resolution occurs than in girls. Sustained squirt of high 
pressure, infected urine reflux into a nonciliated ureter may present the 
greatest potential for acquired renal scarring. 
PATHOPHYSIOLOGY OF VUR: 
1) Immature Bladder: 
Incomplete detrusor/sphincter synchrony6 during voiding results in 
an interrupted urinary flow with intermittent high bladder pressures as the 
detrusor contracts against a closed or only partially relaxed sphincter. 
Immature voiding dynamics and recurrent UTI significantly delay the 
resolution of infantile VUR. It is more probable that the functional 
abnormality lies in an individual’s susceptibility to urinary infection, which 
then effects changes to bladder, ureteral and trigonal function with 
resultant reflux. 
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2. Urinary Infection: 
Infection distorts bladder function and may be the factor in initiating 
many cases of dysfunctional elimination syndromes, whereas others have 
no identifiable cause for bladder instability or detrusor overactivity. 
Reflux Associated Nephropathies: 
The term was first used in 1973 – the congenital reflux nephropathy. It 
may arise through several mechanisms, affecting the developing kidney 
and manifests as a spectrum of abnormalities. Scars are seen as defects in 
Isotope uptake Tc 99m DMSA. The definitive macrosopic features of 
reflux nehropathy are coarse segmental scars, involving cortex and 
medulla, overlying dilated (or clubbed) calyces. Scar contracture with 
hypertrophy of the unaffected renal parenchyma can cause an uneven 
lobular appearance of the renal outline and renal poles are often more 
prominently affected. The changes are interstitial with chronic 
inflammatory cell infiltration7 and lymphoid follicle formation together 
with tubular atrophy and interstial fibrosis. There is 14% incidence of new 
scars during the first 5 years of follow up and rare subsequently. Bilateral 
nephropathy is a high risk factor for chronic insufficiency and the 
development of hypertension. 
Pathogenesis of acquired renal scarring-intra renal reflux: 
Intra renal reflux has a segmental distribution occurring 
predominantly at the renal poles regions where scars are common. 
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There is a direct transmission of bladder pressure8 to the renal 
pelvis and the intra renal back flow occurs as an extension of the 
reterograde dynamics. This exposes the renal tubules to pressures as that 
in bladder, so that urinary pathogens gain access to renal substance. The 
segmental distribution of intrarenal reflux is due to variation in renal 
papillary morphology. Two types of papillae, the compound papilla and 
simple papilla are present. Compound papillae present as flat or concave 
cribiform areas bearing open Belleni ducts allowing intrarenal reflux in 
poles of the kidney. Simple papillae present a convex surface with slit like 
orifices that create a valvular mechanism preventing intrarenal reflux and 
found in mid zone. Ransley and Risdun showed that scar formation in the 
presence of urinary infection occurred only in relation to refluxing papillae 
(i.e) bigbang nature of the acquired scars. 
 
Papillary configuration in intrarenal reflux. (a) Convex papilla (non-refluxing):  
crescentric or slit-like orifices of collecting ducts opening obliquely onto the papilla.  
(b) Concave or flat papilla (refluxing papilla): round, gaping orifices of collecting  
ducts opening at right angles onto flat papilla. 
Urinary Infection: 
Experimental studies after urinary infection with UVR showed rapid 
progression from small direct abscesses reflecting individually affected 
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tubules to coalescent abscess or a confluent mass. Within two weeks 
irreversible scaring occurs and by three weeks scar contracture occurs. 
The use of antimicrobial therapy in one week after infection or 
during early inflammatory phase will limit the extent of scar formation and 
any residual pathology presents as fine linear scars. Hence rapid treatment 
for acute pyelonephritis limits renal damage. 
Acquired Pyelonephritis in the absence of VUR: 
Presence of renal scarring in the absence of VUR is a feature of 
spontaneous resolution of VUR. Alternative explanations for the genesis of 
non-reflux pyelonephritis are 
a) haematogenous spread of infection. 
b) ascending pyelonephritis in the absence of reflux  
c) transient VUR during an acute infection – 99mTc DMSA 
scintigraphy is highly sensitive in detecting the initial stages 
of pyelonephritis. 
Sterile VUR and acquired renal scarring: 
Sterile VUR in itself does not cause renal scars. In severe outlet 
obstruction as in PUV in infants, scarring sometimes involved numerous 
papillae owing to distortion of the papillary morphology and recuritment 
of previously non refluxing papillae. Scar formation resulted from tubular 
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interstitial damage with rapid progression to interstitial collagen deposition 
but without the cellular inflammatory response. 
Pathogenic Mechanism of renal scarring: 
Fibrosis which constitute the scars, results from increased cell matrix 
synthesis and deposition together with a decrease in degradation 
mediators like cytokines, growth factors and angiotension II. Ischaemia 
and reperfusion damage the release of superoxide, and free radicals of 
oxygen destroys lipid cell membranes. 
There is a transient elevation of renal vein renin during early 
inflammatory phase of pyelonephritis due to compression of vasa recta 
and peritubular capillaries by edema or from obstruction of the capillary 
vasculature with platelet and granulocyte aggregation. Reperfusion injury 
can be limited by use of exogenous superoxide dismutase, complement 
depletion, pretreatment with the xanthine oxidase inhibitor-allopurinol. In 
There are no adverse effects of VUR on renal growth9,10 or glomeurlar 
function. 
DIAGNOSIS OF PRIMARY VUR: 
Voiding Cystourethrogram: 
Retrograde imaging of bladder and urethra was first described in 
1905. It’s the principle method for assessing the reflux and classification 
by the International study group into five grades. 
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(a) International classification of vesicoureteral reflux: grade I, ureter only; grade II, ureter, pelvis, 
calices, no dilatation, normal caliceal fornices: grade III, mild or moderate dilatation and/or tortuosity of 
ureter, and mild or moderate dilatation of the pelvis, but no or slight blunting of the fornices; grade IV, 
moderate dilatation and/or tortuosity, of ureter and mild: dilatation of renal pelvis and calices, complete 
obliteration of sharp angle of fornices but maintenance of papillary impressions in majority of calices, 
grade V, gross dilatation and tortuosity of ureter, gross dilatation of renal pelvis and calices, papillary 
impressions are no longer visible in majority of calices. (Modified from International Reflux Committee 
Common Classifications of Vesicoureteral Reflux: 
Description Grade/Classification 
International Study 
Classification 
0 I II III IV V 
Dwoskin-Perlmutter 0 1 2a 2b 3 4 
Birmingham 0 1 2 3 
Australia/NZ  Mild Moderate Severe 
Great Britain  I II 
(Voiding) 
III 
(filling & voiding) 
IV 
(Dilatation) 
International study classification has been used in our study. 
Radionuclide Studies: 
Renal scanning using 99mTc DMSA is the preferred method of 
assessing growth and development of kidneys. 
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Common areas of renal scarring characterized by parenchymal thinning over 
a deformed calyx,  as determined from intravenous pyelograms. The extent of 
scarring may be related to single polar scars;  multiple areas of upper, lower, 
and medial scars; or generalized scarring, as depicted 
 
Ultrasonography studies the upper and lower tract.  Colour 
Doppler USG images the directional flow of urine11. 
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Four different ureteric orifice positions: (a) normal; (b) moderately lateral; (c) very lateral;  
and (d) orifice at the mouth of a diverticulum 
 
Orifice morphology (endoscopic view): (a) normal cone-shaped orifice;  
(b) stadium orifice; (c) horseshoe orifice; (d) lateral pillar defect; and  
(e) golfhole orifice. (Reproduced from Glassberg et al). 
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Other diagnostic modalities. 
1. Magnetic resonance voiding cystography. 
2. PIC cystography – positioning the instillation of contrast – the 
contrast instilled at the orifices will unmask the occult VUR. 
Non Imaging Modalities12  
Measured levels of microproteinuria, urine retinol binding protein, 
urinary prostaglandin F2, urinary B2–microglobulin, TammHorsfall protein, 
B-N-Acetyl Hexosaminidase, Nacetyl D-Glucosaminidase (NAG) Urinary 
interleukin levels, procalcitonin, serum endothelium leukocyte adhesion 
molecule–1 (ELAM-1) are elevated. 
Who should be tested for reflux:13 
 All UTI in 1st year of life in male child. 
 Rec. UTI in female child. 
 One episode of pyelonephritis has 9% incidence of scarring 
where as three attacks had 38% of patients with renal scars. 
 No new scars developed after puberty. 
 Youngest children are at greatest risk for renal scarring from 
bacterial pyelonephritis due to low intra renal reflux pressure, 
immature immune system and delayed recognition of 
pyelonephritis or inadequate treatment. 
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Identical twins have been observed to have reflux by autosomal 
dominant inheritance and Asian and African ancestry have lower 
incidence of reflux. In neonates with antenatal hydronephrosis, 38% had 
reflux even though post natal USG was normal. 
Condition associated with Primary VUR: 
 Renal Agenesis 
 Horshoe kidney and renal ectopia 
 Mutli cystic dysplastic kidney . 
 Prune belly syndrome. 
 Mega cystis – megaureter syndrome. 
 Hypospadias. 
 Duplication, Ureterocele, ectopic ureter 
 Imperforate anus. 
MANAGEMENT OF VUR: 
1) Medical Management 
2) Endoscropic Management 
3) Surgical Management 
1) MEDICAL MANAGEMENT: 
Treating each infection after it was diagnosed was unsafe as, 
though not all children developed scars, it was impossible to predict who 
will be affected. Renal damage on IVP can occur even after one infection. 
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Data from the international reflux study in children showed a high rate of 
new scar formation in children not on continuous prophylaxis. 
In Goldraich and Goldraich’s study there was a 3% rate of new scar 
formation in those on chemoprophylaxis, unilateral reflux (54%) resolved 
slightly more than the bilateral (12%) cases in the international reflux 
study in children. Resolution rates were grade I – 83% Grade II – 60%, 
Grade III – 46%, Grade IV – 9% and grade V – 0%.The mean age of 
resolution was 4.6 years and mean time of resolution was 1.7 years. 
According to Birmingham (United kingdom) Co-operative study: 
Those on chemoprophylaxis – their urine cultures were obtained once in 
every 3 months for 2 years and then once in every 6 months. Renal 
function was studied at 2 and 5 years with creatinin clearance and water 
deprivation tests. 
The indications for surgery were, 
1) Break through infection. 
2) High reflux grade in adolescence. 
3) New renal scars. 
4) Progressive renal insufficiency. 
5) Poor compliance. 
6) UTI after antibiotics were stopped. 
The rate of break through infection was 25%. In the international 
reflux study group there were no new cases of hypertension and GFR was 
not reduced, renal growth was same between the medical and surgical 
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group. The number of new scars or deterioration in renal function was 
equal in surgical and medical groups. There was more febrile UTIs in 
medically managed patients. Most of new scars in surgical group were 
within 1 year of surgery14. Meta-analysis by Wheeler and colleagues 
showed that overall risk of febrile and non febrile GTI occurring in either 
group was the same after 5 years. 
ANTIBIOTIC PROPHYLAXIS: 
Characteristics of commonly used urosuppressive antibiotics 
Drug Therapeutic 
Dose 
Suppressive 
Dose 
How Supplied Comments 
Nitrofurantoin 2 mg/kg PO qid 1 mg/kg PO qid Suspension 
(5mg/mt) Capsule 
(25,50mg) 
Avoid in patients <1 month 
of age. Not effective if CrCl 
<40 ml/min. Nausea 
common with suspension; 
Sprinkling macrocystals may 
avoid this  
Trimethoprim 
sulfamethoxazole 
4 mg/kg 
trimethoprim 
+20 mg/kg 
sulfamethoxazole 
PO bid 
2 mg/kg 
trimethoprim 
+10 mg/kg 
sulfamethoxazole 
PO qd 
Suspension (8 mg 
trimethoprim 
+40 mg 
sulfamethoxazole 
per ML.  
Tablet (80mg 
trimethoprim, 
400mg 
sulfamethoxazole) 
Avoid in patients <1 month 
of age contraindicated with 
hyperbilirubinemia. May 
cause blood dyscrasias and 
Stevens- Johnson syndrome. 
Trimethoprim 
(Primsol) 
5 mg/kg PO bid 2 mg PO qd Oral solution 
50mg/5ml 
Avoid in patients  
<2 months of age. 
Amoxicillin 10mg/kg PO tid 10mg/kg PO qd Suspension 
(25,50 mg/ml)  
Drops 50/mg/ml) 
Avoid in patients  
<2 months of age. 
Cephalexin 25 mg/kg PO bid 25 mg/kg qd Suspension  
125 mg/5ml or 
250 mg/5ml. 
Alternative for neonates 
Indications for Urinary Tract Prophylaxis: 
 Vesicoureteral reflux 
 Recurrent infections with normal urinary tract 
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 Awaiting radiological evaluation after urinary tract infection. 
 Unstable urinary tract abnormality (e.g. partial urinary tract 
obstruction) 
 Urethral instrumentation 
 Immunosuppression or immunocompromise. 
 Infants with first urinary tract infection before 8-12 wk of age. 
Patient compliance was varying from 12-90% with higher 
compliance with high grade reflux. Breakthrough infection is defined as 
the development of an infection with an organism resistant to prophylaxis, 
breakthrough infections are more common if there is voiding dysfunction. 
Scarring occurs mostly after febrile infections. There is no consensus on 
the number of break through infections that can be safely tolerated  
before recommending surgery. Scott reported a 29% rate of cystitis  
after spontaneous resolution. The Birmingham study found that most new 
scars occurred between ages of 2 and 7 years, but scars could progress at 
any age. 
Macharen and Simpson correlated high renal scar rates with reflux 
occurring at low bladder volumes. 
Micromolecular and genetic predictors of scarring are presence of        
1)   DD genotype of the angiotension converting enzyme gene. 
1) Tumour necrosis factor  AA genotype 
2) Tissue Kallikrein promoters 
3) Transforming growth factor B1 
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4) Insulin like growth factor-1 MRNA expression  
5) Interleukin 6 & Interleukin -8 
6) Cyctooxygenase 2 over expression 
7) Urinary endothelin -1 
There are no large, long term prospective studies to establish safe 
guidelines for discontinuing prophylaxis based on grade, sex, race, renal 
scarring or voiding habits. 
Spontaneous resolution rates: 
Study by Edward and Coworkers revealed spontaneous cessation in 
85% of children whose ureters are not dilated and in 40% of children 
whose ureters are dilated. 
Kaplan meier curves predict time course for resolution of reflux15 as 
50% with grade I within 2.5 years, Gr.II with 5 years of diagnosis and 
Gr.III & IV within 8 years of diagnosis. 
Spontaneous resolution in special anatomic situations: 
1) Complete Ureteral Duplication 
High grade lower pole reflux with ureteral dilatation and lower pole 
atrophy have a low resolution rate and needs early surgical correction. 
2) Periureteral bladder diverticulum: 
Large diverticulum with ureter entering directly into it have less 
chance of resolving, than a smaller diverticulum. 
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3) Solitary Kidney: 
Low grade reflux followed medically whereas high grade reflux are 
treated as those for two kidneys. 
4) Intra renal reflux: 
Presence of intra renal reflux is an absolute indication16 of the 
abandonment of a continuous prophylactic regimen. 
5) In antenatally diagnosed dilatation of foetal renal pelvis – 
post natal incidence of VUR even in normal post natal USG is high with 
break through infection in 1st 3 months. 
6) Voiding habits and voiding dysfunction:Double or triple 
voiding will help eliminate bacteria that had returned to the bladder from 
the upper tracts after an episode of reflux during the first void. More 
incidence of breakthrough infection in voiding dysfunction. 
7) Circumcision reduces the incidence of recurrent infection in 
boys younger than 1 year. 
8) Risk of renal failure is less than 1% - 0.5% proteinuria is the 
hall mark of progressive segmental glomerulosclerosis. Hypertension 
develops during adolescence when there is extensive renal scarring which 
account for 14-50 of cases. 
9) Glomerular disease does not recur in the transplanted kidney 
even if it is also refluxing. 
 
32 
10) Renal failure can be accelerated by pregnancy in women with 
pre-existing renal insufficiency and chemoprophylaxis during pregnancy or 
anti reflux surgery before pregnancy is recommended. 
2) ENDOSCOPIC TREATMENT: 
Tissue augmenting substances for endoscopic subureteral injection.  
1) Dextroromer/Hyaluronic acid copolymer 
2) Poly tetra fluro ethylene. 
3) Cross linked bovine collagen. 
4) Polydimethylosiloxane. 
5) Autologus chondrocytes. 
6) Calcium hydroxyl apatite. 
Indications for endoscopic correction of VUR are the same as for 
open anti reflux operations via the cystoscope subureteral injection of 
Deflux is given until a bulge appears in the floor of the submucosal ureter. 
Results of subureteric Teflon injection (STING) is complete 
resolution after 1 injection in 76%, after 2 injections in 12% and after  
3-4 injection in 2%, while symptoms improved in 6% and failed results in 
4% of cases.  
3) SURGICAL MANAGEMENT FOR VUR: 
Absolute indication for surgical correction failures of medical 
management17. Specifically break through febrile UTIs. 
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Relative indications include massive reflux (Grade IV & V) 
associated congenital abnormalities of VUR, secondary reflux. 
Bacteriuria has been reported in 40% of patients after successful 
surgery, although most do not develop pyelonephritis. Renal growth 
retardation or the presence of new renal scars dilating reflux persisting in 
girls who have reached full somatic growth potential. Hutch first reported 
the successful correction of VUR in 1952. The Goal of surgical correction 
is the restoration of the flap valve mechanism. 
History: 
The first reported ureteroneocystostomy was by Tanffer in 1877. 
Later Bovee described 80 cases of ureteral reimplant. In 1952, Hutch 
reported the successful correction of VUR by a combined extra vesical and 
intra vesical dissection. 
Many surgical techniques have been described Politano and Lead 
better described intravesical mobilization of the terminal ureter with 
subsequent reimplantation through a new vesical hiatus and submucosal 
tunnel. Paquin’s requirements for a successful VUR surgery include a 
tension free ureteral anastamosis and a submucosal tunnel length five 
times longer than the diameter of the ureter. 
Extravesical approach was described by Lich. Gregoir & Van 
Regemorter simultaneously. Glenn and Anderson used modified ureteral 
advancement technique without creating a new muscular hiatus in 1960’s. 
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Cohen then modified the ureteral advancement procedure – achieved 
adequate submucosal tunnel length by using posterior aspect of the 
bladder for cross trigonal tunneling. 
Cystoscopy is performed prior to reimplantation surgery to evaluate 
the lower urinary tract. 
Surgical Techniques: 
Intra Vesical Techniques: 
Child is placed in supine position. Pfannenstiel skin incision is made 
and the anterior rectus sheath is opened in a horizontal fashion with 
superior and inferior rectus flaps. By extra peritoneal approach, the 
bladder is opened longitudinally after taking stay sutures. Moist sponges 
are placed in the dome of bladder and Denis brown retractor is used for 
exposure and to flatten the posterior bladder wall. This elevates the lower 
half of the bladder bringing the ureteral orifices into the middle of the 
operative field. Ureters are intubated with 3 or 5 Fr feeding tubes and 
mobilized with caution to avoid devascularisation. 
a) Politano-lead better Technique: 
The original politano-lead better technique was described in 1958. 
Ureter is mobilised, posterior bladder wall dissection is performed under 
vision and freed from peritoneum. A right angle clamp is passed through 
the original hiatus in a superior direction and hugging the posterior wall 
and marking the new site for entrance of ureter. The new hiatus location is 
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slightly medial and cephalad 2-3 cm above the original hiatus. Avoid 
excessive kinking of ureter and the original muscular opening is closed. 
Ureter enters through a new hiatus and a submucosal tunnel 
inferomedially towards the bladder neck. Ureter is fixed all around. A 
modification of politano – lead better original method is increasing the 
submucosal tunnel length. 
 
 
Conceptual comparison of techniques to correct reflux. A common theme  
is the achievement of a long length of intravesicalureter based on a  
strong detrusor floor and covered with compressible urothelium. 
b) Cohen’s cross trigonal repair: 
First described by Cohen in 1975. After ureteral mobilization, a 
submucosal tunnel is created along the posterior bladder wall without 
transferring the ureter to a new muscular hiatus. The major disadvantage 
of this procedure is the difficult intubation of the ureteral orifices after 
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surgery related to their transtrigonal location. New mucosal hiatus is 
created above the contralateral ureteral orifice. In bilateral reimplant the 
other ureter is brought to the new orifice close to the inferior portion of 
the old contralateral ureteral orifice. 
c) Glens – Anderson Repair: 
In 1967 Glenn Anderson popularized this technique which is used 
for laterally displaced  ureters and a sufficient posterior bladder wall 
mucosal tunnel directed caudally and ureteral orifice is placed superior to 
the bladder neck. 
d) Gil Vernet Repair: 
Described in 1984, for those with lateral ectopia and widened 
mega-trigone. Advancing the mobile ureters across the trigone by using 
traction sutures placed at medial aspect of ureteral orifices. Mattress  sutures 
advance the ureters towards the midline increasing their intramural length.  
Extravesical Techniques: 
a) Lich-Gregoir Repair: 
This approach was described simultaneously by Lich-Gregoir and 
Van Regemorter in 1960. In this bladder is not opened, cystoscopy is 
performed to rule out any bladder abnormalities. 
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Bladder is partly filled. Ureters are exposed at its entrance in the 
posterior bladder wall and mobilized. The serosal and muscular layers of 
the detrusor are incised superiorly for a distance of 4-5cm to create a 
trough for ureter. The bulging bladder mucosa is seen. The ureter is 
advanced and anchored and placed in the trough. The detrusor is closed 
over it. Perivesical drain are not routinely used. 
Specific Advantages and Disadvantages of commonly 
performed antireflux procedures 
 
 
POST-OPERATIVE EVALUATION: 
Surgical repair of VUR via a catheterless uretero neocystostomy 
reduces hospital stay without increasing complication rates. Post surgical 
management includes renal USG at one month to assess the presence of 
hydronephrosis. 
as
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Chemoprophylaxis is continued for 3-6 months following surgery. 
Yearly follow up of voiding history, BP, urine analysis and renal USG  
are done. 
A success rate for surgical method is 94-99%. The American 
Urological Assocition (AUA) Paediatric Vesicoureteral Reflux guidelines 
panel found an overall success rate of 95.6%. Reimplanted ureters with 
grade I-IV UVR – had a surgical correction rates of 98-99% regardless of 
the technique. Grade V VUR have been found to have a persistant lower 
grade VUR in 19% of cases following surgery. 
SURGICAL COMPLICATIONS: 
Ureteral Obstruction: 
Mild hydrorephrosis may occur in early post operative period which 
resolved over a period of several months. Persistant hydronephrosis is 
related to ureteral obstruction. Initial management is by placement of 
percutaneous nephrostomy tube or indwelling stent. If obstruction persists, 
a repeat reimplant is required. A psoashitch or Boariflap, transuretero 
ureterostmy or ileal ureter may be received for reconstruction for given 
ureter length. 
Persistent reflux: 
Success rate is more than 98%. Adequate submucosal tunnel and 
ureteral tapering in dilated ureters are needed. In most cases reflux is 
downgraded and resolve with growth and good voiding habits. One 
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unusual cause of persistent VUR is the development of a ureterovesical 
fistula following reimplant surgery and needs surgical correction. 
New Contralateral Reflux: 
Following unilateral ureteric implant, new contralateral VUR occurs 
in 1-18%. Possible factors are prior history of resolved contralateral reflux, 
correction of Grade-V VUR and VUR into a duplicated system. It usually 
resolves in 1-2 years with good voiding regimen and rarely surgery is 
needed. 
The open surgical repair for the correction of VUR is both a safe 
and effective management option. Politano-leadbetter and Cohens’ cross 
trigonal methods are successful and used widely. Though laparoscopic 
and endourologic techniques are being performed in greater numbers, the 
ease and success of the open surgical repair is the standard by which all 
other repairs should continue to be judged. 
1. The open surgical correction of vesico ureteral reglux is highly 
effective, has few complications, and is the current gold standard 
treatment. 
2. The appropriate intravesical surgical technique is determined by 
trigonal anatomy. 
3. The modified politano-leadbetter repair involves the creation of 
a new suprahiatal location of the ureter under direct vision. 
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4. When creating a new suprahiatal location for the ureter during 
the modified politano-lead better repair it is important to avoid 
lateral placement to prevent J looking of the ureter. 
5. The cross trigonal method of ureteral reimplantation results in 
less potential for kinking because of its use of the original 
muscular hiatus. 
6. The major drawback to the cross trigonal method is the 
subsequent difficult intubation of the ureteral orifice due to its 
position following surgery. 
7. The Glenn-Anderson technique is highly successful when used in 
those patients with laterally displaced ureters, allowing for 
sufficient ureteral advancement and tunnel length. 
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Treatment recommendations: Boys & Girls with primary 
vesicoureteral reflux and with renal scarring 
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Treatment recommendations: Boys and Girls with Primary 
Vesicoureteral Reflux and No Renal Scarring 
 
 
According to the 1977 AUA guide lines, Medical treatment is 
preferred to surgery in early infancy because of a higher rate of 
spontaneous resolution. However its also been shown that the incidence 
of pyelonephritis was twice as high in patients treated with antibiotic 
prophylaxis than those treated surgically and once pyelonephritis occurs 
infants are more susceptible to renal scarring than older children. 
The success of medical line of therapy can be judged on the basis of 
the following: 
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a) Reflux resolution – lower grade reflux has a better chance of 
resolving. 
b) Renal scarring – many studies show no statistical difference 
in rate of new scarring treated medically or surgically. The 
Birmingham reflux study identified new scars after 5 years in 
6% of medically treated and 5.2% of surgically treated 
patients. 
c) Renal growth and function – No evidence to show that renal 
growth is impaired in unscarred kidneys exposed to sterile 
reflux of any grade. Though surgical correction stabilizes the 
GFR it does not lead to long term improvement. 
d) Urinary tract infection – in children with grade II-IV VUR the 
incidence of pyelonephritis is higher in medically treated than 
in those who underwent surgical therapy. 
So comprehensive medical therapy involves good bladder training 
and continuous antibiotic prophylaxis. 
Cases in which there is parenteral anxiety regarding long term 
effects of antibiotic prophylaxis in infants and children and x-ray exposure 
for repeated VUG as well as psychological trauma due to urethral 
catherisation and in some groups such as those with uncontrollable UTI, 
urosepsis or non compliance of medical treatment, surgical treatment may 
be reasonable to avoid further renal damage and may be socially indicated. 
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MATERIALS AND METHODS 
This a prospective study conducted in the department of pediatric 
surgery, Institute of Child health over a period of 2½ years. 
This study was performed between August 2009 and January 2012 
for primary vesico ureteral reflux. 
Apart from the clinical examination, baseline investigation, blood 
parameters, ultrasonogram – voiding cystourethrogram intravenous 
urogram and DMSA scan were taken. 
Patients were followed up for and more year post operatively for 
resolution of reflux and urinary tract infection. 
Patients treated surgically were compared with those treated with 
chemoprophylaxis alone in terms of recurrent urinary tract infections and 
resolution of reflux as demonstrated by voiding cystourethrogram. 
SELECTION CRITERIA: 
Inclusion Criteria: 
All patients with primary vesico ureter reflux (i.e due to intrinsic 
defect within the ureterovesical junction) irrespective of grade or laterality. 
Exclusion Criteria: 
All patients with secondary vesico ureteral reflux as a result of another 
pathology like associated bladder outlet obstruction (posterior urethral valve) 
and neurogenic bladder dysfunction are excluded from the study. 
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OBSERVATION 
This is a prospective study conducted in department of pediatric 
surgery ICH and HC over a period of 2½ years August 2009 – January 2012. 
The following facts were obtained. During this study period 35 patients 
who met the selection criteria attended the paediatric surgery department. 
Age Distribution in Numbers: 
Age No. of cases 
Neonate 1 
Infant 4 
1-3 years 16 
3-5 years 5 
>5 years 9 
Total 35 
Range – neonate to 12 years. 
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Age Distribution in Percentage: 
Age % of cases 
Neonate 2.9% 
Infant 11.4% 
1-3 years 45.7% 
3-5 years 14.3% 
>5 years 25.7% 
TOTAL 100% 
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Sex Distribution: 
Sex No. of cases Percentage 
Male 22 62.9% 
Female 13 37.1% 
Total 35 100% 
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SEX DISTRIBUTION
37.10%
62.90%
Male
Female
 
Laterality Distribution: 
Laterality No. of cases Percentage 
Unilateral (R) or left 13 37.7% 
Bilateral 22 62.9% 
TOTAL 35 100% 
Ratio 
Unilateral : Bilateral = 1: 1.7 
37.10%
62.90%
0%
10%
20%
30%
40%
50%
60%
70%
N
O
.O
F 
C
A
SE
S
Unilateral Bilateral
LATERALITY
LATERALITY DISTRIBUTION
Unilateral
Bilateral
 
 
48 
MCU SHOWING VARYING GRADES OF REFLUX 
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MCU SHOWING VARYING GRADES OF REFLUX 
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Grade of Reflux: 
Grade of vesico  
ureteral reflux 
No. of Renal Units Percentage 
Grade I  1 1.8% 
Grade II 8 14.3% 
Grade III 13 23.2% 
Grade IV 24 42.8% 
Grade V 10 17.9% 
Total 56 100% 
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Hypertension: 
Hypertension was present in 1 patient. 
Urine Culture: 
All patients had history of urinary tract infection with urine culture 
positive for E.coli. 
Blood Urea and Creatinine: 
Blood urea & creatinine were raised in    3 cases 
 Blood urea & creatinine were raised normal in 32 cases 
        -------------- 
       Total  35 cases 
         -------------- 
Ultrasound: 
In ultrasound examination an increase in diameter of the ureter 
and/or renal pelvis was observed as a sign of reflux. 
Bilateral uretero hydronephrosis was detected in 3 cases antenately. 
Associated findings in USG:  
Contracted/small kidney size  - 4 cases 
Double moiety   - 2 cases 
Non visualized / absent kidney - 1 case 
MCDK    - 1 case 
Antenately diagnosed bilateral ureterohydronephrosis – 3 cases 
Presenting complaint: 
Recurrent urinary tract  - 32 cases 
Asymptomatic   - 3 cases 
     -------------- 
 Total     - 35 cases 
      -------------- 
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All patients underwent voiding cystourethrogram (VCUG) and were 
graded according to the criteria of the international reflux study committee. 
Micturating cystourethram was done in all patients preoperatively 
and on post operative follow up. 
During the study period one case was lost for follow up while on 
medical management. 
Medical Management  -   6 cases 
Surgical Management  - 29 cases 
TOTAL    - 35 cases 
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DMSA scan  
DMSA scan done     - 31 cases 
DMSA Not done*    - 4 cases 
     -------------- 
Total      - 35 cases 
      -------------- 
* DMSA not done due to non affordability in 3 cases and loss of 
follow up in 1 case. 
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DISTRIBUTION OF DMSA SCAN STATUS
4
32
DMSA scan done
DMSA scan not done
 
DMSA Scan 
DMSA scan Positive for scars   - 30 cases 
         Negative for scars  - 1 case 
     -------------- 
 Total     - 31 cases 
      -------------- 
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99MTC DMSA RENAL SCINTIGRAPHY 
 
Study is negative for multiple renal scars in both kidneys 
 
 
 
Study is Positive for multiple renal scars in both kidneys. 
There is relatively prominent involvement of the Left kidney 
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Horse shoe kidney with multiple renal scars in the upper pole 
of the less dominant Right kidney 
 
 
 
Study is Positive for multiple renal scars in both kidneys. 
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CYSTOSCOPY: 
Cystoscopy done in 30 cases. 
 Findings: 
 Patulous ureteral orifice   25 cases 
 Normal ureteral orifice   5 cases 
Cystoscopy not done in 5 cases. 
 Cystoscopy was not done as 4 patients were not willing  
for the cystoscope and 1 patient lost follow up. 
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TYPES OF SURGERY: 
Cohens Reimplant: 
 Unilateral - Right   5 cases 
    - Left  10 cases 
 Bilateral   14 cases 
    -------------- 
Total   29 cases 
     -------------- 
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Lich Gregor & Lead better: 
In one failed case with 2 renal units out of 29 cases in Cohens 
procedure, 1 renal unit underwent Lich Gregor and another 1 renal unit 
underwent Lead Better procedure. 
Ureteric Reimplantation: 
Stented   21 cases 
Non stented   8 cases 
    ------------- 
Total     29 cases 
    ------------- 
URETERIC REIMPLANTATION - STENT STATUS
8
21
Stented
Non stented
 
FOLLOW UP: 
All cases were followed up with a) monthly culture sensitivity for  
3 months, b) USG at 3 monthly intervals for 6 months then yearly,  
c) MCU was done at one year post operatively.  
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All patients were placed on post op chemoprophylaxis for 6 months.  
Five patients had one episode of UTI within 6 months due to non 
compliance of chemoprophylaxis and they have recovered with intra 
venous antibiotics. 
 
Reflux Resolution: 
Total no. of renal units in our study : 56 renal units 
 Surgically treated   : 46 renal units 
 Medically treated    : 10 renal units 
Reflux Resolution:    
 With Primary Surgery  : 44 renal units 
 With resurgery   :  2 renal units* 
  for persistent reflux 
 In Medical Management  5 renal units 
* one patients with 2 renal units with resurgery had complete resolution.  
 
So, 44 renal units treated by primary surgery had complete 
resolution of reflux. 
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Complete Resolution of reflux  
Medical & Surgical (Primary Surgery & resurgery) 
 No. of Renal Units Percentage 
Grade I 1 1.8% 
Grade II 5 63% 
Grade III 13 100% 
Grade IV 24 100% 
Grade V 8 80% 
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INTRA OPERATIVE PICTURE 
CRANIAL 
 
 
 
 
 
 
 
 
POST OPERATIVE MCU 
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Complete Resolution of reflux with initial primary surgical 
management is 44 out of 46 renal units with the percentage of 95.6%. 
We experienced no post operative ureterovesical junction obstruction 
in our study, but only persistent reflux of lower grade in 2 renal units in 
one patient. The patient was undertaken for resurgery successfully. 
The relative benefit of medical and surgical treatment of VUR, in 
our study is in favour of surgical management for the above observations. 
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DISCUSSION 
 
During this study period of 2½ years from August 2009 - Jan.2012, 
a total of 35 patients reported to the Department of Pediatric Surgery with 
signs and symptoms of primary vesico ureteric reflux. 
In our study, 35 patients who fulfilled the criteria were taken into 
account and formed a total of 56 renal units. Out of these, 46 renal units 
were managed with surgery, 10 renal units were managed medically.  
Out of these 46 renal units who had underwent primary surgery,  
44 renal units got resolution of reflux with success percentage of 95.6%. 
The remaining 2 renal units in one patient underwent resurgery.  
The primary surgical technique followed in our study is Cohens Reimplant 
in all 46 renal units and 44 renal units had complete resolution. In the  
2 failed renal units, one renal unit was managed by Lich Gregor and other 
renal unit was managed by Lead better. 
Out of the 10 renal units who had undergone medical management, 
5 got resolution of reflux with success percentage of 50%.  
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OUR STUDY - SURGERY OUTCOME
4.40%
95.60%
Success
Failure
 
Our study results were compared with many international studies 
and found to be comparable. 
The Briminglrams reflux study group over a period of 5 years had 
105 successful resolutions out of 107 renal units with surgical techniques 
of Cohen, Lich & Lead better (mainly Cohens). Success rate in this study 
is 98% which is comparable with our study. 
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BRIMINGHAM'S STUDY - SURGERY OUTCOME
2%
98%
Success
Failure
 
In the Glassberg study over a period of 5 years, they had 100% of 
success rate of the 101 renal units surgically only with Cohen’s technique 
which is very much comparable with our study. 
In this American Urological Association Panel study the success rate 
was 99% (108/109) which is also comparable with our study. 
AMERICAN UROLOGICAL ASSOCIATION 
PANEL - SURGERY OUTCOME
1.00%
99.00%
Success
Failure
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CONCLUSION 
1. Majority of cases presented at an age of <3 years and all 
were symptomatic with history of recurrent UTIs. 
2. Male female ratio was 1:0.6, predominately males in our study. 
3. Bilateral cases were 62.9% as compared to 37.1% unilateral cases. 
4. Grade III, IV, V reflux constituted 83.9% of total renal units. 
5. Type of surgery was predominantly Cohen’s Reimplant with 
success rate of 95.6%. 
6. In ultrasonogram, an increase in diameter of the ureter 
and/or renal pelvis was observed as a sign of reflux. 
7. Micturiting cystourethrogram is an investigation tool for 
grading the reflux pre operatively and for the detection of 
post operative resolution.   
8. Surgery is the preferred option for persistent Gr.III & IV and 
all Gr.V reflux. 
9. Many patients who eventually required surgical management 
had already suffered kidney damage. So, early referral for 
surgical intervention would reduce the number and extent of 
renal damage due to reflux.  
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PROFORMA – PRIMARY VUR 
Name:      Age:   M/F 
Address: 
 
IPL No.      Wt   DOS 
Diagnosis: 
Grade:    Unilateral/Bilateral  Age at diagnosis: 
 Pre Operative Post Operative 
Weight   
Blood – urea   
Creatinine   
Electrolytes   
Urine c/s   
No. of UTI   
RP   
USG – Renal size   
Ureter   
MCU   
IVU   
DTPA/DMSA   
Others   
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Cystoscopy- 
Type of reimplant- 
Age at surgery – 
Stent -    Yes/No 
POST op complications – 
Chemoprophylaxis duration –  
Follow up – age at present- 
Recurrence 
Symptoms 
Resurgery 
No. of UTI 
CRF 
USG – Renal size 
Ureter 
MCU 
DTPA/DMSA 
Others 
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MASTER CHART 
MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
1. Dharshine  1 ½  
F 
704828  1yr   N  –  RU 0.7cm 
LU 0.9cm 
III  V  Faint 
excretion LK 
Multiple 
B/L 
scars 
  LUO‐
patulous 
RUO‐difficult 
to visualize 
B/L 
Cohen’s 
  Gr.II 
Lt. 
Rept. 
MCU N
One 
episode 
at 3 
months
 
2. Prem  6 yrs  
M 
515715  4yr   N  –  B/L PCS 
prominent 
RK 5.5 cm 
LK 3.8cm 
III  II  B/L prompt 
excretion 
Upper 
pole B/L 
+ve  
  Both UO ‐ 
Normal 
–  –  N  –   
3. Vignesh  10 yrs 
M 
708847  10yr   N  –  LK‐contr. 
5.6 cm 
RK 8.5cm 
  V  LK mild UHN 
RK ‐ N 
B/L +ve  –  LUO 
patulous 
Lt. Cohen’s    N  –   
4. Arunraj  10 yrs 
M 
703787  8yrs   N  –  Rt. UHN  
RU 0.6cm 
II  II  B/L prompt 
excretion  
scars + 
dilated 
tortuous 
ureter B/L  
  Not done  –  –  B/L 
Gr.II  
–   
5. Keerthana  10 yr  
F 
719296  8 yrs   N  –  RK Cont. 
 
III  II  RK not 
visualized 
Upper 
poles  +ve 
LK – 85% 
RK – 15% 
 RUO 
patulous 
B/L 
Cohen’s 
  N  –  
6. Sanjana  1 ½ yr  
F 
718327  1 yr   N  –  B/L  double 
moiety 
B/L UHN  
RK – 8.2cm 
RU – 1.2cm
LK – 8.9cm
LU ‐ 2.0 cm  
III  IV  B/L double 
moiety, 
retention in 
both sides 
+ve   B/L golf hole 
ureter 
B/L 
Cohen’s 
common 
sheath 
reimplant, 
Rt. single 
cohen 
  N  once  
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MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
7. Kirubakaran  1 ¼  yr 
M 
743219  1¼ yrs   N  –  B/L HN  
L > R 
RK – 6.4cm
LK – 7cm 
V  IV  B/L prompt 
excretion 
+ve  – RUO 
patulous 
with small 
periureteric 
diverticulum
B/L 
Cohen’s 
–  N  –  
8. Girthish  9/12  
M 
718801  9/12 
months 
 N  –  B/L UHN 
RK ‐6.5cm 
LK ‐6.8cm 
RU ‐2.4cm 
LU ‐0.7cm 
IV  III  Rt. UHN 
draining in 
6hrs,  
Lt. UHN hold 
up  
in 6hrs 
+ve  – RUO 
patulous 
B/L 
Cohen’s 
  N  –  
9. Mylarasi  2 ½ yrs 
F 
718240  1 yr   N  –  B/L UHN 
RK – 8.4cm
LK – 7.3cm 
III  II  B/L draining 
well 
Rt. polar 
+ve 
RK – 48% 
LK – 52% 
 Not done  –  –  B/L 
Gr.II 
–  
10. Jeeva  2 yrs  
M 
713350  2yrs   N  –  Lt. UHN 
LK – 9.4cm
LU – 1.5cm 
  V  Lt. HN hold 
up in 6 hrs 
RK – 94% 
LK – 6% 
+ve 
– RUO – N 
Lt. para 
ureteric 
diverticulum
Lt. Cohen’s 
with 
diverti‐
culectomy 
  N  once  
11. Suresh  1 ¼ yrs 
M 
574321  1 ¼ yrs   N  –  B/L UHN 
RK – 6.5cm
LK – 6.5cm
RU ‐ 0.6cm
LU ‐ 0.8cm 
  IV  drains 
completely in 
6 hours 
LK  ‐ +ve 
RK  – 69% 
LK – 31% 
– normal  B/L 
Cohen’s 
–  N  –  
12. Hariharan  2 yrs  
M 
676043  1yr   N  –  B/L UHN 
RU – 0.8cm
LU – 0.4cm 
 
 
IV  I  B/L bifid 
pelvis with 
polycalycosis
+ve   RUO 
patulous  
Rt. Cohen’s –  N  –  
 
73 
MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
13. Ragul 
Kishore 
4 yrs 
M 
676106  4 yrs   N  –  RK  Cortical 
Echos 
RK – 8.2cm
LK – 8.0cm 
  IV  LK delayed 
excretion  
+ive  – LUO close to 
para ureteric 
diverticulum
Lt. Cohen’s 
with 
diverti‐ 
culectomy 
  Lt. Gr.II 
Rept. 
MCU N
once  
14. Deva 
dharshani 
7 yrs 
F 
491796  7 yrs   Cr. 
mild
–  B/L UHN  III  III  B/L prompt 
excretion 
+ve  – both UO 
patulous 
B/L 
Cohen’s 
  N  –  
15. Surya 
Narayanan 
2 ½ yrs 
M 
490475  2 ½ yrs   N  –  B/L UHN  
RK – 8.8cm
LK – 9cm 
RU – 0.4cm
LU – 0.5cm 
IV  IV  B/L prompt 
excretion 
+ve  – Laterally 
placed UO 
B/L 
B/L 
Cohen’s 
–  N  –  
16. Divya  4 yrs 
F 
684423  4 yrs  N N  –  RK not 
visualized, 
LK HN ‐ 6cm
LU ‐ 1.3cm 
    RK not 
visualized 
No scars  – UOs not 
visualized 
small 
congested 
bladder  
Lt. Cohen’s   N  –  
17. Bhava 
Saravanan 
4 yrs 
M 
606322  4 yrs   N    RK – 7.3cm
LK ‐ small 
5.9cm 
  IV  Lt. UHN  Lt. polar 
+ve  
  
– LUO 
patulous 
Lt. Cohen’s –  N  –  
18. Keerthika  3 yrs 
F 
677564  3 yrs   N  –  B/L UHN 
RK – 6.9cm
LK – 7.1cm
RU ‐ 0.8cm
LU ‐ 0.6cm 
IV  IV  LK delayed 
excretion 
multiple 
B/L +ve 
RK – 63% 
LK – 37% 
– normal  B/L 
Cohen’s 
–  N  –  
19. Kavya  1 yr 
F 
720634  6 
months 
 N  –  Rt. UHN 
RK – 6.7cm
LK – 6.2cm
RU – 0.4cm
LK – 0.8cm 
IV    –  Multiple 
B/L +ve 
 Both UOs 
visualized 
Rt. Cohen’s   N  –  
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MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
20. Vignesh  9 yrs 
M 
727561  7 yrs   N  –  LK ‐ PCS 
dilatation 
LK – 6.2cm
RK – 9.0cm
Lt. lower 
ureter seen 
  III  Lt. Sec. PUJO Rt. upper 
pole +ve 
RK – 92% 
LK – 8% 
 RUO – N 
LUO larger 
Lt. Cohen’s   N  –  
21. Thasmin 
banu 
2 yrs 
F 
742600  2yrs   N  –  RU – 0.9cm
LU – 0.9cm 
IV  IV  draining 
completely in 
6 hrs 
multiple 
B/L +ve 
RK – 50% 
LK – 50% 
– BUO 
patulous 
Laterally 
placed 
B/L 
Cohen’s 
–  N  –  
22. Naresh 
kumar 
10 yrs 
M 
743312  10 yrs   N  –  B/L UHN 
RK – 7.8cm
LK – 7.6cm
RU – 0.7cm
LU – 0.3cm 
III    draining 
completely in 
4 hrs 
multiple 
B/L +ve  
RK – 21% 
LK – 79% 
– RUO 
laterally 
placed 
Rt. Cohen’s   N  –  
23. Sharmila  6 yrs 
F 
651055  6yrs   N  –  RK – 8.2 cm
LK – 4.6cm
LU 1.1cm 
  III  LK delayed 
excretion 
LK Cortical 
+ve  
RK – 75% 
LK – 25% 
– Not done  –  –  N  –  
24. Rena Juliet  4 yrs 
F 
559259  4 yrs    –  Rt. UHN 
double 
moiety  
V    RK not 
visualized 
RK +ve 
RK – 15% 
LK  – 85% 
– Ruo 
patulous 
Lead 
better 
politano 
Rt. 
  Gr.II 
Rept. 
MCU N.
once  
25. Ashok  3 yrs 
M 
663791  3 yrs   N  –  B/L mild pcs 
dilatation 
RK – 4.3cm
LK – 8.1cm
RU – 0.7cm 
 
III  III  B/L prompt 
excretion 
RK +ve 
RK ‐ 15% 
LK ‐ 85% 
– BUO 
patulous 
B/L 
Cohen’s 
  N  –  
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MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
26. Devendran  5 yrs 
M 
622123  3yrs   N  –  B/L UHN 
 
II  V  B/L prompt 
excretion 
LK Cortical 
+ve 
 Normal  B/L 
Cohen’s 
  N  –  
27. Rahul 
Kumar 
7 yrs 
M 
590429  7 yrs   N  –  B/L UHN    V  B/L prompt 
excretion 
B/L +ve  – Normal  Lt. Cohen’s –  N  –  
28. Vinoth  2 yrs 
M 
538166  2 yrs   N  –  Rt. UHN 
Lt. MCDK 
IV    LK not 
visualized 
RK +ve  – LUO not 
visualized 
Rt. Cohen’s   N  –  
29. Vignesh  3 ¼ yrs 
M 
521414  3 
MONTHS 
   –  RU – 2.1cm
LU ‐1.2cm 
IV  IV  –  RK – 74% 
LK – 26% 
– BUO 
patulous 
Lt. Cohen’s 
repeat Lt. 
lich 
gregeor, 
Rt. Cohen’s
  B/L 
VUR 
Re‐
surgery 
then 
MCU N
once  
30. Karthigayan  2 ¼ yrs 
F 
677564  2 ¼ yrs  N  –  B/L UHN 
RU ‐ 0.6cm
LU ‐ 0.6cm 
IV  IV  draining 
completely in 
6 hrs 
B/L cold 
areas 
present 
RK – 63% 
LK – 37% 
– BUO 
patulous 
laterally 
placed 
B/L 
Cohen’s 
  N  –  
31. Asen Goswa  3 yrs 
M 
642084  6 
months
 N  –  RK – 4.8cm
cor.thickness 
0.5cm 
LK – 8.5cm
Normal 
Cortex 
IV  III  RK delayed 
excretion 
RK – 17% 
LK – 83% 
+ve 
 LUO 
patulous 
Lt. Cohen’s   N  –  
32. Satheeswari  1 ¼ yrs 
F 
653513  1 ¼ yrs – N  –  B/L UHN  III  III  draining 
completely in 
6 hrs 
Polar B/L 
+ve 
RK – 45% 
LK – 55% 
 
– Not done  –  –  Lt. Gr.II –  
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MCU Grade Follow up 
S.No  Name  Age/Sex  I.P. No. 
Age at 
Diagnosis 
Rec 
UTI
Blood. 
U/C 
  HT    USG 
R  L 
IVU 
DMSA‐ 
scars 
Pre op 
Chemo
Pre op Cysto‐
scopy 
Type of 
Reimplant 
stent
 MCU    Rec. UTI 
Chemop‐
rophylaxis
33. Vijayakumar  3 yrs 
M 
648798  3 yrs  N  –  B/L UHN 
Lt. > Rt. 
RU – 0.3cm
LU – 1.1cm 
IV  V  LK delayed 
excretion 
Not done  – B/L golf hole 
UOs 
B/L 
Cohen’s 
  N  –  
34. Srinivasan  2 ½ yrs 
M 
648657  2 ½ yrs N  –  B/L UHN 
RK – 10.7cm
LK – 10.5cm
RU – 1.1cm
LU – 1.2cm 
IV  V  B/L prompt 
excretion 
Not done  – B/L para 
ureteric 
diverticulum
B/L 
Cohen’s 
  N  –  
35. B/o. Valli  14 days 
M 
651085  AN diag 
B/L 
UHN 
 
‐ N  –  B/L UHN 
RU – 0.6cm
LU – 0.8cm 
II  IV  ‐  Not done   ‐  –  –  Lost to follow up
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PATIENT INFORMATION SHEET 
AIM OF THE STUDY 
In primary vesicoureteric reflux this study is to do analysis of post 
surgical outcome in Primary vesicoureteric reflux; a 3 year study among 
the children admitted in Institute of Child Health, Egmore, Chennai a 
tertiary referral hospital and also a premier state apex pediatric institute. 
All data will be kept strictly private and confidential. You may 
choose to take part or not in this study. That is your choice. No penalties 
or loss of benefits will come from refusing. Even if you have choosen to 
take part, you may refuse to answer any question. Even if you do not take 
part in this study, as per the treatment protocol the treatment strategies 
will be the same. 
If you have any doubts regarding this study, you can meet the 
investigator to get them clarified. In this study all investigations are done 
at free of cost. The treatment given is also free of cost. 
 
78 
SECTION – II 
INFORMATION CONSENT FORM 
I agree to participate in the study titled Primary vesicoureteric 
reflux an analysis of Post surgical outcome in primary vesicoureteric 
reflux. 
I confirm that I have been told about this study in my mother 
tongue and I had the opportunity to ask question. I confirm that I have 
been told about risk and potential benefits for my child participation. 
I understand that my child participation is voluntary and I may 
refuse to continue at any time without giving any reason without my 
child's benefits being affected. 
1. Name of the Child 
2.      Name of the Guardian/Care Giver : 
 Signature : 
 Date : 
3.      Name of the Witness : 
 Signature : 
 Date : 
4.      Name of the Investigator : 
 Signature : 
 Date : 
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Primary Vesico Ureteric Reflux 
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